Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517264 | SCV000613133 | uncertain significance | not specified | 2016-10-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001438989 | SCV001641870 | likely benign | Duchenne muscular dystrophy | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002376952 | SCV002668719 | uncertain significance | Cardiovascular phenotype | 2021-09-29 | criteria provided, single submitter | clinical testing | The c.7201-4A>G intronic variant results from an A to G substitution 4 nucleotides upstream from coding exon 50 in the DMD gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003144305 | SCV003830025 | uncertain significance | not provided | 2020-01-26 | criteria provided, single submitter | clinical testing |